Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.0259
Delayed Data
As of Aug 18
 -0.0028 / -9.76%
Today’s Change
0.01
Today|||52-Week Range
0.20
-48.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues22.9K24.2K4.3K0.00
 
 
 
 
Cost of Goods Sold2.0K15.5K2.2K0.00
 
 
 
 
Depreciation And Amortization12.0K15.7K14.8K15.8K
 
 
 
 
 
 
Operating ExpensesGross Income8.9K-7.0K-12.7K-15.8K
 
 
 
 
 
General Expenses2.4M2.2M2.6M5.4M
 
 
 
 
 
Total Operating Expenses2.5M2.2M2.6M5.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.2M-2.6M-5.4M
 
 
 
 
 
Extraordinary Credit--0.000.002.9M
 
 
Extraordinary Charge-197.8K0.00-2.7M-363.3K
 
 
 
 
Interest Expense On Debt267.6K178.8K1.5M2.4M
 
 
 
 
 
Other Expenses1.8K1.4M0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.9M-959.5K-6.8M-5.3M
 
 
 
 
 
Income Taxes-532.000.000.000.00
 
 
Net Income-2.9M-959.5K-6.8M-5.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS697.3K30.3M96.8M117.4M
 
 
 
 
 
Shares To Calculate EPS Diluted697.3K30.3M96.8M117.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$0.03-$0.07-$0.05
 
 
 
 
 
EPS Diluted-$4.00-$0.03-$0.07-$0.05